GAUGLER DARYL 4
4 · Pacira BioSciences, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
GAUGLER DARYL
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-06-05$38.74/sh−1,000$38,740→ 23,591 total - Sale
Common Stock
2023-06-07$37.87/sh−1,047$39,645→ 21,539 total - Sale
Common Stock
2023-06-06$38.99/sh−1,005$39,186→ 22,586 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.